Intel is actively courting additional large investors for a discounted equity infusion beyond SoftBank's recently announced $2 billion investment, according to sources familiar with the matter who spoke to CNBC's David Faber. The move comes as the struggling chipmaker faces mounting pressure from the Trump administration to grant government equity stakes in exchange for CHIPS Act funding, creating a complex financing puzzle that could reshape Intel's ownership structure.
Intel just complicated its already messy financing drama. The chipmaker is quietly shopping for additional large investors willing to buy equity at a discount, expanding beyond SoftBank's freshly announced $2 billion lifeline, sources tell CNBC. The revelation sent Intel shares tumbling more than 7% Tuesday, erasing gains from earlier optimism about the SoftBank deal and potential Trump administration support.
The timing couldn't be more precarious. Commerce Secretary Howard Lutnick told CNBC Tuesday that the U.S. government "must receive an equity stake in Intel in exchange for CHIPS Act funds" - a demand that threatens to dilute existing shareholders while Intel desperately needs private capital. "They need money to build whatever it is that the customers may actually, ultimately want," CNBC's David Faber said on "Squawk on the Street." "And having the CHIPS Act money, which is free, so to speak, no strings attached, become equity is not helpful to them because it's dilutive."
This puts Intel in an impossible position. The company has been hemorrhaging market share to competitors like NVIDIA and AMD while missing the AI semiconductor boom entirely. Intel's manufacturing ambitions - a cornerstone of CEO Lip-Bu Tan's turnaround strategy - require massive capital infusions to compete with TSMC and other established foundries. Yet securing that funding means either accepting dilutive government ownership or paying premium rates to private investors.
The political dimension adds another layer of complexity. President Donald Trump initially called for Tan to resign two weeks ago, branding him "highly CONFLICTED" before softening his stance after the CEO's White House visit. This volatility has created uncertainty among potential investors who must now factor political risk into their Intel calculations.
SoftBank's $2 billion commitment provided temporary relief, but industry analysts question whether even combined private and government funding can reverse Intel's fortunes. The company's foundry business has yet to secure major customers beyond internal Intel chip production, while competitors continue gaining ground in both manufacturing and design. Intel's stock has lost over 60% of its value in the past two years, making it an attractive target for value investors but raising questions about execution capability.
The discount equity talks signal Intel's acknowledgment that traditional debt financing won't suffice for its ambitious manufacturing expansion. Unlike government CHIPS Act funds, private equity allows Intel to maintain operational independence while accessing growth capital. However, offering shares at below-market prices indicates management's recognition that Intel's current valuation may not attract institutional investors at full price.
Competitor reactions have been swift. NVIDIA shares jumped 3% Tuesday as investors bet Intel's struggles will continue benefiting the AI chip leader. Qualcomm and Broadcom also saw modest gains, suggesting the market views Intel's financing challenges as validation of current industry dynamics rather than a temporary setback.
For Intel, the stakes couldn't be higher. The company's manufacturing strategy depends on proving it can build cutting-edge semiconductors for external customers - a capability that requires both technological advancement and massive capital investment. Without adequate funding, Intel risks falling further behind in both manufacturing and design, potentially triggering a death spiral in the world's most capital-intensive industry.
Intel's pursuit of discounted equity funding beyond SoftBank reveals the depth of its financial predicament and the complexity of navigating both market pressures and political demands. While additional private investment could provide necessary capital without government dilution, the discount pricing suggests institutional skepticism about Intel's turnaround prospects. The company's ability to secure favorable terms from multiple investors while satisfying political stakeholders may determine whether Intel can execute its manufacturing strategy or faces continued decline in the global semiconductor race.
